Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Trends in kinase selectivity: insights for target class-focused library screening.

Posy SL, Hermsmeier MA, Vaccaro W, Ott KH, Todderud G, Lippy JS, Trainor GL, Loughney DA, Johnson SR.

J Med Chem. 2011 Jan 13;54(1):54-66. doi: 10.1021/jm101195a. Epub 2010 Dec 3.

PMID:
21128601
2.

Orthogonality of SFC versus HPLC for small molecule library separation.

Weller HN, Ebinger K, Bullock W, Edinger KJ, Hermsmeier MA, Hoffman SL, Nirschl DS, Swann T, Zhao J, Kiplinger J, Lefebvre P.

J Comb Chem. 2010 Nov 8;12(6):877-82. doi: 10.1021/cc100118y. Epub 2010 Oct 5.

PMID:
20923153
3.

Enhancing the reagent selection workflow via real-time vendor inventory.

Nirschl DS, Hermsmeier MA, Silber G, Logan JV, Hammar R, Young DL.

J Comb Chem. 2009 Mar 9;11(2):206-9. doi: 10.1021/cc8001603. No abstract available.

PMID:
19053504
5.

Are target-family-privileged substructures truly privileged?

Schnur DM, Hermsmeier MA, Tebben AJ.

J Med Chem. 2006 Mar 23;49(6):2000-9.

PMID:
16539387
6.

Solid-phase synthesis of 5-substituted amino pyrazoles.

Dodd DS, Martinez RL, Kamau M, Ruan Z, Van Kirk K, Cooper CB, Hermsmeier MA, Traeger SC, Poss MA.

J Comb Chem. 2005 Jul-Aug;7(4):584-8.

PMID:
16004502
7.

Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments.

Good AC, Hermsmeier MA, Hindle SA.

J Comput Aided Mol Des. 2004 Jul-Sep;18(7-9):529-36.

PMID:
15729852
8.

Genetic Algorithm guided Selection: variable selection and subset selection.

Cho SJ, Hermsmeier MA.

J Chem Inf Comput Sci. 2002 Jul-Aug;42(4):927-36.

PMID:
12132894
9.
10.

Prospective identification of biologically active structures by topomer shape similarity searching.

Cramer RD, Poss MA, Hermsmeier MA, Caulfield TJ, Kowala MC, Valentine MT.

J Med Chem. 1999 Sep 23;42(19):3919-33.

PMID:
10508440
11.

Diversity assessment.

Mason JS, Hermsmeier MA.

Curr Opin Chem Biol. 1999 Jun;3(3):342-9. Review.

PMID:
10359714
12.

Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.

Chen P, Cheng PT, Alam M, Beyer BD, Bisacchi GS, Dejneka T, Evans AJ, Greytok JA, Hermsmeier MA, Humphreys WG, Jacobs GA, Kocy O, Lin PF, Lis KA, Marella MA, Ryono DE, Sheaffer AK, Spergel SH, Sun CQ, Tino JA, Vite G, Colonno RJ, Zahler R, Barrish JC.

J Med Chem. 1996 May 10;39(10):1991-2007.

PMID:
8642558
13.

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.

Patick AK, Rose R, Greytok J, Bechtold CM, Hermsmeier MA, Chen PT, Barrish JC, Zahler R, Colonno RJ, Lin PF.

J Virol. 1995 Apr;69(4):2148-52.

14.

Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.

Barrish JC, Gordon E, Alam M, Lin PF, Bisacchi GS, Chen P, Cheng PT, Fritz AW, Greytok JA, Hermsmeier MA.

J Med Chem. 1994 Jun 10;37(12):1758-68.

PMID:
8021916
15.

Supplemental Content

Loading ...
Support Center